- PROSTAGLANDIN A1
- Prostaglandin A2
- Prostaglandin D2
- Prostaglandin E1
- Prostaglandin E2
- Prostaglandin E2 sodium salt
- PROSTAGLANDIN F1ALPHA
- Prostaglandin F2 methyl ester
- Prostaglandin F2a
- Prostaglandin F2a tris salt
- 36327-91-04-Pyrimidinecarboxaldehyde,1,2,3,6-tetrahydro-2,6-dioxo-
- 3632-91-5Magnesium gluconate
- 36330-85-53-(4-Biphenylylcarbonyl)propionic acid
- 36330-86-6Benzenebutanoic acid, g-oxo-4-phenoxy-
- 36331-57-4Benzenemethanesulfonicacid, hydrazide
- 3633-17-8Hexanoicacid, 6-amino-, ethyl ester, hydrochloride (1:1)
- 36333-48-9Arsonic acid, tridecyl-(9CI)
- 36335-67-8Phosphoramidothioicacid, N-(1-methylpropyl)-, O-ethyl O-(5-methyl-2-nitrophenyl) ester
- 36338-96-24-Cyclohexene-1,3-dione,6-b-D-glucopyranosyl-2-[[(3S)-3-b-D-glucopyranosyl-2,3,4-trihydroxy-5-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-6-oxo-1,4-cyclohexadien-1-yl]methylene]-5,6-dihydroxy-4-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-,(2Z,6S)-
- 36339-04-5b-Alanine,N-[5-(acetylamino)-2-methoxyphenyl]-, 2-methoxyethyl ester
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Prostaglandin E2 |
EINECS | 206-656-6 |
| CAS No. | 363-24-6 | Density | 1.148 g/cm3 |
| PSA | 94.83000 | LogP | 3.25110 |
| Solubility | ethanol: 1 mg/mL | Melting Point |
66-68 °C |
| Formula | C20H32O5 | Boiling Point | 530.1 °C at 760 mmHg |
| Molecular Weight | 352.471 | Flash Point | 288.5 °C |
| Transport Information | N/A | Appearance | white to pale yellowish-cream powder |
| Safety | 53-22-26-36/37/39 | Risk Codes | 60-22 |
| Molecular Structure |
|
Hazard Symbols |
 T
|
| Synonyms |
5-Heptenoicacid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]- (8CI);(-)-Prostaglandin E2;(15S)-Prostaglandin E2;11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11a,13E,15S);11a,15a-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid;Cervidil;Cerviprime;Dinoprostone;Enzaprost E;Minprositin E2;NSC 196514;PGE2;Primiprost;Prostaglandin E2;Prostenon;Prostenone;Prostin (prostaglandin);U 12062;Vivelle-Dot;l-Prostaglandin E2; |
Article Data | 32 |
Prostaglandin E2 Chemical Properties
Molecular Formula:C20H32O5
Molecular Weight:352.52
EINECS:206-656-6
Density:1.148g/cm3
Melting Point:66-68°C
Boiling Point:530.1°Cat760mmHg
Flash Point:288.5°C
Solubility:insoluble
Properties:Crystals
Dinoprostone's Synonyms: Prostaglandin E2;9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID;7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid;(5Z,11A,13E,15S)-11,15-DIHYDROXY-9-OXO-PROSTA-5,13-DIEN-1OIC ACID;[5Z,11ALPHA,13E,15S]-11,15-DIHYDROXY-9-OXOPROSTA-5,13-DIEN-1-OIC ACID;[5Z,11ALPHA,13E,15S]-11,15-DIHYDROXY-9-OXOPROSTA-5,13-DIENOIC ACID;PROSTAGLANDIN;PROSTAGLANDIN E2
Prostaglandin E2 Uses
Induction of labor
Prostaglandin E2 Toxicity Data With Reference
| 1. | oms-mus:oth 100 nmol/L | JIDEAE Journal of Investigative Dermatology. 66 (1976),313. | ||
| 2. | spm-mus-ipr 3 mg/kg | INJFA3 International Journal of Fertility. 21 (1976),82. | ||
| 3. | dns-gpg:lng 1 mg/L | PSEBAA Proceedings of the Society for Experimental Biology and Medicine. 171 (1982),109. | ||
| 4. | orl-rat LD50:500 mg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 8 (1974),787. | ||
| 5. | scu-rat LD50:31,600 µg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 8 (1974),787. | ||
| 6. | ivn-rat LD50:59,500 µg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 8 (1974),787. | ||
| 7. | orl-mus LD50:750 mg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 8 (1974),787. | ||
| 8. | scu-mus LD50:19,700 µg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 8 (1974),787. | ||
| 9. | ivn-mus LD50:23,200 µg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 8 (1974),787. | ||
| 10. | ipr-ham LD50:1 mg/kg | PLMEDD Prostaglandins, Leukotrienes and Medicine. 17 (1985),309. |
Prostaglandin E2 Safety Profile
Poison by subcutaneous and intravenous routes. Moderately toxic by ingestion and intraperitoneal routes. An experimental teratogen. Human reproductive effects by intravenous, intraplacental, and intravaginal routes: changes in the uterus, cervix and vagina; termination of pregnancy; and changes in fertility. Experimental reproductive effects. Mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.
Dinoprostone's Safety Information
Hazard Codes T
Risk Statements 60-22
Safety Statements 53-22-26-36/37/39
WGK Germany 3
RTECS UK8000000
F 8-10
Prostaglandin E2 Specification
Dinoprostone's Handling and Storage
【Storage】Keep container closed when not in use. Deep freeze (below -20 C). Store protected from light. Store with dessicant.
【Handling】Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. Store protected from light. Use only in a chemical fume hood.
What can I do for you?
Get Best Price
